# Pharmacodynamics of Lorelin Depot (Leuprorelin Acetate - Bergamo) Compared to Lupron Depot ® (Leuprorelin Acetate - Abbot)

> **NCT01071005** · PHASE1 · COMPLETED · sponsor: **Azidus Brasil** · enrollment: 58 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Lorelin Depot Bergamo
- **DRUG:** Lupron Depot - Abbott

## Key facts

- **NCT ID:** NCT01071005
- **Lead sponsor:** Azidus Brasil
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2010-10
- **Final completion:** 2011-01
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2013-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01071005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01071005, "Pharmacodynamics of Lorelin Depot (Leuprorelin Acetate - Bergamo) Compared to Lupron Depot ® (Leuprorelin Acetate - Abbot)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01071005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*